Afficher la notice abrégée

Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic

dc.rights.licenseopenen_US
dc.contributor.authorLARROUQUERE, L.
dc.contributor.authorGABIN, M.
dc.contributor.authorPOINGT, E.
dc.contributor.authorMOUFFAK, A.
dc.contributor.authorHLAVATY, A.
dc.contributor.authorLEPELLEY, M.
dc.contributor.authorKHOURI, C.
dc.contributor.authorBELLIER, A.
dc.contributor.authorALEXANDRE, J.
dc.contributor.authorBEDOUCH, P.
dc.contributor.authorBERTOLETTI, L.
dc.contributor.authorBORDET, R.
dc.contributor.authorBOUHANICK, B.
dc.contributor.authorJONVILLE-BERA, A. P.
dc.contributor.authorLAPORTE, S.
dc.contributor.authorLE JEUNNE, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLETINIER, Louis
dc.contributor.authorMICALLEF, J.
dc.contributor.authorNAUDET, F.
dc.contributor.authorROUSTIT, M.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOLIMARD, Mathieu
dc.contributor.authorRICHARD, V.
dc.contributor.authorCRACOWSKI, J. L.
dc.date.accessioned2021-02-01T16:00:09Z
dc.date.available2021-02-01T16:00:09Z
dc.date.issued2020
dc.identifier.issn0767-3981 (Print) 0767-3981en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26088
dc.description.abstractEnOn March 16, 2020, the French Society of Pharmacology and Therapeutics put online a national Question and Answer (Q&A) website, https://sfpt-fr.org/covid19 on the proper use of drugs during the COVID‐19 pandemic. The working group ‘Drugs and COVID‐19’ was composed of a scientific council, an editorial team, and experts in the field. The first questions were posted online during the first evening of home‐confinement in France, March 17, 2020. Six weeks later, 140 Q&As have been posted. Questions on the controversial use of hydroxychloroquine and to a lesser extent concerning azithromycin have been the most consulted Q&As. Q&As have been consulted 226 014 times in 41 days. This large visibility was obtained through an early communication on Twitter, Facebook, traditional print, and web media. In addition, an early communication through the French Ministry of Health and the French National Agency for Medicines and Health Products Safety ANSM had a large impact in terms of daily number of views. There is a pressing need to sustain a public drug information service combining the expertise of scholarly pharmacology societies, pharmacovigilance network, and the Ministry of Health to quickly provide understandable, clear, expert answers to the general population’s concerns regarding COVID‐19 and drug use and to counter fake news.
dc.language.isoENen_US
dc.subjectPharmacoEpi-Drugs
dc.title.enGenesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic
dc.title.alternativeFundam Clin Pharmacolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/fcp.12564en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalFundamental and Clinical Pharmacologyen_US
bordeaux.page389-396en_US
bordeaux.volume34en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03127829
hal.version1
hal.date.transferred2021-02-01T16:00:14Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Fundamental%20and%20Clinical%20Pharmacology&rft.date=2020&rft.volume=34&rft.issue=3&rft.spage=389-396&rft.epage=389-396&rft.eissn=0767-3981%20(Print)%200767-3981&rft.issn=0767-3981%20(Print)%200767-3981&rft.au=LARROUQUERE,%20L.&GABIN,%20M.&POINGT,%20E.&MOUFFAK,%20A.&HLAVATY,%20A.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée